0001179110-15-000377.txt : 20150105 0001179110-15-000377.hdr.sgml : 20150105 20150105195515 ACCESSION NUMBER: 0001179110-15-000377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150102 FILED AS OF DATE: 20150105 DATE AS OF CHANGE: 20150105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001436304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 BUSINESS PHONE: 818-587-4500 MAIL ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: David Nathaniel E CENTRAL INDEX KEY: 0001559531 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35663 FILM NUMBER: 15507679 MAIL ADDRESS: STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC. STREET 2: 27200 WEST AGOURA ROAD, SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 4 1 edgar.xml FORM 4 - X0306 4 2015-01-02 0 0001436304 KYTHERA BIOPHARMACEUTICALS INC KYTH 0001559531 David Nathaniel E C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362 1 0 0 0 Common Stock 2015-01-02 4 S 0 1016 35.20 D 483781 D Common Stock 2015-01-02 4 S 0 424 35.69 D 483357 D Common Stock 2015-01-02 4 S 0 240 35.00 D 483117 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $34.61 to $35.54, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $35.59 to $35.80, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Keith Klein, as Attorney-in-Fact for Nathaniel E. David 2015-01-05